
|Articles|October 26, 2020
Pharmacy Times: Week of October 26 Lineup
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Advertisement
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:
- A video interview with Daniel Flaherty, PhD, assistant professor of medicinal chemistry and molecular pharmacology at Purdue University, and Mohamed Seleem, PhD, professor in the Department of Biomedical Sciences & Pathobiology at Virginia Polytechnic Institute and State University, about a molecule developed to fight a vancomycin-resistant enterococcus, which is a superbug.
- A new episode of the Pharmacy Focus podcast with Brooke Griffin, 21st Century PharmD, about what students can learn from the coronavirus disease 2019 pandemic.
- On Wednesday, Pharmacy Times will publish a clinical review of the first FDA-approved treatment for peanut allergy—Palforzia.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
3
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5

















































































































































































































